News

DTSKF

Immunomedics (IMMU) Plunges After Pricing Public Offering

Joel Anderson | Equities.com |

Shares in biopharmaceutical company Immunomedics (IMMU) were down sharply on Friday following the announcement of pricing for the upcoming public offering of some 9 million new shares. The


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Jorge Fernandez - iBlades

Equities.com's Sam Mitchell interview iBlades CEO, Jorge Fernandez